Evan Unger
Gründer bei Nuvox Pharma LLC
Aktive Positionen von Evan Unger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Nuvox Pharma LLC
 Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Gründer | - | - | |
| Präsident | - | - | |
NuvOx Therapeutics, Inc.
 NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Gründer | - | - | |
| Präsident | - | - |
Karriereverlauf von Evan Unger
Ehemalige bekannte Positionen von Evan Unger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Direktor/Vorstandsmitglied | 01.10.1999 | - |
Ausbildung von Evan Unger
| University of California, Berkeley | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Nuvox Pharma LLC
Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Commercial Services |
NuvOx Therapeutics, Inc.
NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Evan Unger
- Erfahrung
